Company / Working Capital per Share
Supernus Pharmaceuticals, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$5.49
FY2025
5-year range
$0.87 / $7.19
FY2021-FY2025
Trend
-23.7%
vs FY2024
Sector context
#105 of 210
Health Care
What the data says
At $5.49, Supernus Pharmaceuticals, Inc.'s working capital per share ranks #105 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $0.87 in FY2022 to $7.33 in FY2020.
Based on SEC 10-K filings.
5.49 in FY2025 with a 5-year CAGR of -5.6%.
Improved from $3.66 to $5.49 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +85.0%
- 5-Year CAGR
- -5.6%
- 10-Year CAGR
- -
Sector benchmark
#105 of 210 in Health CareTop 50% of 210This company $5.49 Sector average $146.86
▼
-96.3% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 23.7% year-over-year.
- Ranks #105 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.49 | -23.7% |
| FY2024 | $7.19 | +96.8% |
| FY2023 | $3.66 | +321.5% |
| FY2022 | $0.87 | -84.0% |
| FY2021 | $5.41 | -26.2% |
| FY2020 | $7.33 | +23.0% |
| FY2019 | $5.96 | -7.8% |
| FY2018 | $6.47 | +206.7% |
| FY2017 | $2.11 | +46.3% |
| FY2016 | $1.44 | +26.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026